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Abstract 
Should this space be here? 
Background: Drosophila has six receptor protein tyrosine phosphatases (RPTPs), 
five of which are expressed primarily in neurons. Mutations in all five affect axon 
guidance, either alone or in combination. Highly penetrant central nervous system 
(CNS) and motor axon guidance alterations are usually observed only when specific 
combinations of two or more RPTPs are removed. Here, we examine the sixth RPTP, 
Ptp4E, which is broadly expressed. 
Results: Ptp4E and Ptp10D are closely related type III RPTPs. Non-drosophilid insect 
species have only one type III RPTP, which is closest to Ptp10D. We found that 
Ptp4E mutants are viable and fertile. We then examined Ptp4E Ptp10D double 
mutants. These die before the larval stage, and have a mild CNS phenotype in which 
the outer longitudinal 1D4 bundle is frayed. Ptp10D Ptp69D double mutants have a 
strong CNS phenotype in which 1D4 axons abnormally cross the midline and the 
outer and middle longitudinal bundles are fused to the inner bundle. To examine if 
Ptp4E also exhibits synthetic phenotypes in combination with Ptp69D, we made 
Ptp4E Ptp69D double mutants and Ptp4E Ptp10D Ptp69D triple mutants. No 
phenotype was observed in the double mutant. The triple mutant phenotype differs 
from the Ptp10D Ptp69D phenotype in two ways. First, the longitudinal tracts appear 
more normal than in the double mutant; two or three bundles are observed, although 
they are disorganized and fused. Second, axons labelled by the SemaIIB-τMyc marker 
often cross in the wrong commissure. We also examined motor axon guidance, and 
found that no phenotypes are observed in any Ptp4E double mutant combination. 
However, triple mutants in which Ptp4E Ptp10D was combined with Ptp69D or 
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Ptp52F exhibited stronger phenotypes than the corresponding Ptp10D double 
mutants. 
Conclusions: Type III RPTPs are required for viability in Drosophila, since Ptp4E 
Ptp10D double mutants die before the larval stage. Unlike Ptp10D, Ptp4E appears to 
be a relatively minor player in the control of axon guidance. Strong phenotypes are 
only observed in triple mutants in which both type III RPTPs are eliminated together 
with Ptp69D or Ptp52F. Our results allow us to construct a complete genetic 
interaction matrix for all six of the RPTPs. 
 
Background 
Signalling via tyrosine phosphorylation is essential for axon guidance in many 
systems. Target proteins involved in signal transduction and cytoskeletal dynamics in 
growth cones are phosphorylated by tyrosine kinases (TKs) and dephosphorylated by 
tyrosine phosphatases (PTPs). 
 
In a simplified view of phosphotyrosine pathways controlling cell growth and 
differentiation, signaling is triggered by engagement of receptor tyrosine kinases 
(RTKs) by ligands. Ligand binding induces receptor dimerization and 
phosphorylation of downstream targets. RTK signalling is downregulated by 
dephosphorylation of autophosphorylated RTKs and other signalling molecules by 
cytoplasmic PTPs. In this scenario, the PTPs are passive modulators of a process in 
which the 'informational' event that initiates signalling is ligand binding to the RTK. 
 
In contrast, phosphotyrosine signalling pathways involved in growth cone guidance in 
the Drosophila embryonic central nervous system (CNS) involve receptor tyrosine 
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phosphatases (RPTPs) and cytoplasmic TKs. Like RTKs, RPTPs are modular 
signalling receptors. They have cell adhesion molecule-like extracellular (XC) 
domains, linked via a single transmembrane region to one or two cytoplasmic PTP 
domains. Five of the six fly Rptp genes are selectively expressed in CNS neurons, and 
all of these genes have loss-of-function phenotypes that affect axon guidance [1-6]. 
 
The TK that is central to many growth cone guidance events in the Drosophila 
embryo is Abl, a cytoplasmic kinase [7-9]. Drosophila has many RTKs, but no 
functional RTK has been implicated in embryonic axon guidance (the kinase-related 
axon guidance receptors Derailed and Off-track are thought to lack enzymatic 
activity) [10,11]. These facts suggest that phosphotyrosine signalling in growth cones 
could be controlled in a manner opposite to that used in RTK pathways. In this 
scheme, the growth cone would use a cytoplasmic TK to constitutively phosphorylate 
targets, and the 'information' that alters signalling strength would be transmitted via 
engagement of RPTPs by ligands located on the surfaces over which the growth cone 
travels. 
 
Of course, this is a greatly oversimplified picture, because there are many other 
receptors that can influence phosphotyrosine signalling in embryonic growth cones. 
For example, the Roundabout 1 (Robo1) receptor is an essential regulator of axon 
guidance across the midline. Phosphorylation of Robo1 by Abl may be regulated by 
Robo1's engagement of its ligand Slit, and in this case the 'information' that triggers 
signalling would be delivered via Slit binding to Robo1 [9]. Also, it is unlikely that 
phosphorylation by Abl is an unregulated, constitutive process. Nevertheless, it is 
striking that the receptors are kinases and the cytoplasmic modulators are 
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phosphatases in pathways that regulate cell growth, while the reverse seems to be true 
for pathways that control neuronal growth cone guidance. 
 
RPTP pathways are poorly understood relative to RTK pathways, partially because in 
vivo ligands that regulate axon guidance and synaptogenesis have been identified only 
for the Drosophila Lar RPTP. These are the heparan sulfate proteoglycans Syndecan 
and Dallylike [12,13]. However, Lar also has non-heparan sulfate proteoglycan 
ligands [14,15], and ligands for the other five fly RPTPs have not yet been defined. It 
has also been difficult to identify substrates that are important for RPTP signalling in 
vivo. 
 
Five Drosophila RPTPs have been genetically characterized in published papers. Four 
of these (Ptp10D, Lar, Ptp69D, Ptp99A) are expressed only on CNS axons in late 
embryos [16-18], and the fifth, Ptp52F, is CNS-specific but is expressed on both 
axons and cell bodies [5]. All of the published zygotic phenotypes for these genes are 
alterations in axon guidance, suggesting that this is the major function of this gene 
family in Drosophila. In contrast, many mammalian RPTPs are expressed in non-
neural tissues and have functions unrelated to axon guidance. 
 
The RPTPs regulate both CNS and motor axon guidance. There is extensive 
redundancy among the five genes, so that highly penetrant guidance phenotypes are 
usually observed only when two or more RPTPs are genetically removed. Studies of 
motor axon guidance indicate that each guidance decision made by motoneuron 
growth cones requires a specific subset of the RPTPs. For example, axons in the ISNb 
nerve are unable to defasciculate from the common ISN pathway in Lar Ptp69D 
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Ptp99A triple mutants. The later decision by ISNb axons to enter their target muscle 
field fails in Lar single mutants, so that the axons bypass the muscle field, but the 
bypass phenotype is suppressed and muscle field entry restored in Lar Ptp99A double 
mutants [19]. This example illustrates that RPTPs can exhibit either functional 
redundancy, in which the absence of one RPTP is compensated for by another RPTP, 
or competition, in which removal of a second RPTP suppresses the guidance errors 
caused by the absence of the first RPTP. Similar genetic interactions among RPTPs 
may also occur in vertebrates, as two recent papers show that double mutant 
combinations and RNA interference perturbations involving the vertebrate Lar and 
type III (Ptp10D-like) RPTP subfamilies produce complex alterations in motor axon 
guidance [20,21]. 
 
In this paper, we examine the functions of the sixth and last Drosophila RPTP, Ptp4E. 
This protein is closely related to Ptp10D, and is the product of a recent gene 
duplication. Unlike the other RPTPs, Ptp4E is widely expressed in late embryos. 
When we began these studies, we thought that Ptp4E mutations might have 
phenotypes affecting many non-neural tissues, since loss of Ptp4E could not be 
compensated for by neural-specific RPTPs. However, our findings show that Ptp4E 
single mutants have no detectable phenotypes, because Ptp4E is redundant with the 
closely related Ptp10D. Double mutant embryos lacking both of these RPTPs die at 
hatching, but they have specific phenotypes affecting only CNS axons and tracheal 
cells. 
 
Here we describe the axon guidance phenotypes produced by Ptp4E mutant 
combinations. The tracheal phenotypes will be described elsewhere (MJ and KZ, 
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manuscript in preparation). The data in this paper, together with those in earlier papers 
from our group [4,5,19], allow us to construct complete pairwise interaction matrices 
that define how all six Drosophila RPTPs regulate CNS and motor axon guidance. 
 
Results and discussion 
Evolution of Ptp4E 
Ptp10D and Ptp4E are clearly the result of a gene duplication that occurred much 
more recently than the split between the other Drosophila Rptp genes. The amino acid 
sequences of their catalytic PTP domains share 89% identity, versus 36-40% identity 
for pairwise comparisons of Ptp4E with other Drosophila RPTPs. Their XC domains 
have a very similar organization, containing chains of 11 FN3 repeats in Ptp4E and 12 
FN3 repeats in Ptp10D, and are 58% identical in amino acid sequence (Figure 1c). 
The Ptp4E gene encodes two predicted preproteins, of 1,767 and 1,607 amino acids, 
while the Ptp10D gene encodes preproteins of 1,931 and 1,631 amino acids. The 
sequences that differ between the alternative gene products are at the carboxyl 
terminus in both cases, but there is no sequence similarity between the Ptp4E and 
Ptp10D proteins within this region. Both genes reside on the X chromosome, and the 
nine Ptp4E introns within conserved coding sequence all correspond exactly in 
position to Ptp10D introns. Ptp10D has one additional intron not found in Ptp4E. 
 
The Caenorhabditis elegans gene dep-1 is the ortholog of both Ptp10D and Ptp4E. 
Humans and mice have five genes encoding type III RPTPs, defined as proteins with 
XC domains composed of long chains of FN3 domains and a single PTP domain. 
Among these, the product of the PTPRB gene (PTPβ, not to be confused with RPTPβ, 
which is a different protein also known as PTPζ) has a somewhat higher alignment 
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score to Ptp10D and Ptp4E than the other four mammalian type III proteins. These 
are: DEP-1/CD148, encoded by the Ptprj gene; PTPRO; SAP-1, encoded by the Ptprh 
gene; and PTPRQ. Since the radiation into the five mammalian genes seen today 
occurred after the split between arthropods and mammals, one cannot define any of 
the type III mammalian genes as an ortholog of one of the fly genes. A more complete 
description of the relationships among all the Drosophila, C. elegans, and mammalian 
RPTPs is found in [5]. 
 
The recent availability of genome sequences from twelve different Drosophila 
species, three mosquito species, two hymenopterans, a beetle, and the silkmoth 
allowed us to trace the evolution of the Ptp10D/Ptp4E gene pair within insect 
lineages. Surprisingly, we find that the Ptp4E gene is found only in drosophilid 
species. Mosquitoes, which are also dipterans, and all other sequenced insects have 
only a single Rptp gene corresponding to this gene pair. This gene is always much 
more closely related to Ptp10D than to Ptp4E. In addition, the Ptp4E sequence 
exhibits more sequence diversity among the drosophilid species than does the Ptp10D 
sequence. These data indicate that Ptp10D is the ancestral gene and that its sequence 
has been constrained more by evolution than the Ptp4E sequence since the time of the 
duplication. Ptp4E has evolved much more rapidly, suggesting that it may have 
acquired new function(s) since its emergence or was less essential for fitness than 
Ptp10D. These relationships are displayed in the phylogenetic tree of Figure 1d. 
 
The Ptp10D ortholog found in all insect species always contains the Ptp10D-specific 
intron, and all Ptp4E orthologs in drosophilids lack this intron. This suggests that the 
intron may have been lost at the time of the duplication from the copy that evolved 
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into Ptp4E. This would have been between 235 million years ago (the estimated time 
at which the mosquito and fly lineages diverged from each other) and 40 million years 
ago (the estimated time at which the radiation among the 12 sequenced drosophilid 
species occurred) [22,23]. 
 
We attempted to trace the history of the duplication by examining the genes adjacent 
to Ptp10D and Ptp4E, but found that the organizations of the Ptp10D and Ptp4E 
regions in D. melanogaster arose long after the Ptp10D and Ptp4E genes diverged 
from each other. Ptp10D is flanked by the Rst(1)JH and bifocal genes. Rst(1)JH is 
found upstream of the Ptp10D ortholog in both the obscura and melanogaster groups, 
but is separated from it in D. willistoni and all other drosophilids. bifocal orthologs 
are adjacent to the Ptp10D gene only in the melanogaster group. Similarly, the two 
genes flanking Ptp4E, SIP3 and CG4068, are located next to the Ptp4E ortholog only 
within the obscura and melanogaster groups. There are no significant sequence 
similarities between the genes that flank Ptp10D and Ptp4E. See [24] for a 
phylogenetic tree displaying the relationships among the sequenced insect species. 
 
Characterization of Ptp4E mutations 
We generated a deletion mutation in Ptp4E, denoted Ptp4E1, by imprecise excision of 
a P element, EP425, located upstream of the putative transcription start site. This 
mutation removes the first and second exons, thus deleting the sequences encoding the 
initiating methionine and the first 67 amino acids of the Ptp4E protein (Figure 1a). 
 
Ptp4E1/Y males are viable, fertile, and apparently healthy, as are Ptp4E1/Df(1)ovo4 
females. We could not detect any alterations in the CNS or neuromuscular system in 
 - 10 - 
embryos or larvae of these genotypes. Df(1)ovo4/Y embryos also had no CNS or 
neuromuscular system phenotypes that could be detected by antibody staining. To 
determine if the absence of a loss-of-function phenotype for Ptp4E is due to 
compensation by the closely related Ptp10D protein, we constructed Ptp4E1 Ptp10D1 
double mutants. Ptp10D1 is an excision mutation that removes the amino-terminal 
coding sequences of Ptp10D [3]. Ptp10D1 animals are viable and fertile, and also have 
no detectable defects in their embryonic nervous systems. In contrast, Ptp4E1 
Ptp10D1/Y animals can hatch out into first instar larvae, but die immediately after 
hatching. To ensure that this lethality is not due to other mutations on these 
chromosomes that confer lethality when combined in the Ptp4E1 Ptp10D1 
recombinant chromosome, we also made a double mutant chromosome containing 
independently isolated insertions just upstream of Ptp4E (Ptp4EKG2328) and Ptp10D 
(Ptp10DEP1172). This chromosome is also lethal in hemizygous males (Ptp4EKG2328 
Ptp10DEP1172/Y). These data confirm the hypothesis that the viability of animals 
lacking either Ptp4E or Ptp10D is due to compensation by the other protein. 
 
Expression of Ptp4E mRNA and protein 
The published in situ hybridization data suggest that Ptp4E mRNA is ubiquitously 
expressed in late embryos, although there are some level differences between tissues 
[25]. To further analyze expression, and to ensure that the observed pattern was not 
affected by cross-hybridization between the closely related Ptp4E and Ptp10D 
phosphatase domain sequences, we repeated this analysis using a probe from the first 
four Ptp4E exons, which are not closely related to Ptp10D. 
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In gastrulating embryos, Ptp4E mRNA is enriched in the invaginating mesoderm 
(Figure 2a). In germ band extended embryos (stage 10-11), the strongest expression is 
observed in the posterior midgut primordium. There is also an interesting ‘scalloped’ 
pattern of expression observed at the ectodermal border (Figure 2b,c, vm). This has an 
intriguing correspondence to visceral mesoderm dpERK staining [26], suggesting that 
Ptp4E may be enriched at sites of RTK activation. Interestingly, thisbe, which 
encodes a ligand for the fibroblast growth factor receptor Heartless -, is expressed in a 
similar pattern [27]. Figure 2d is a germ-band extended embryo expressing a UAS-
linked Ptp4E-green fluorescent protein (GFP) fusion from the engrailed-GAL4 driver. 
This shows the expected striped pattern of expression, confirming that the probe 
recognizes Ptp4E and allowing an estimate of the relative levels of driven versus 
endogenous Ptp4E mRNA. 
 
At stage 14, Ptp4E is widely expressed, with highest levels observed in the midgut. 
Expression in the CNS can also be seen (Figure 2e). Finally, at stage 17 expression is 
much higher in the gut than elsewhere, with particularly strong expression observed in 
the hindgut and at the anterior end of the midgut (Figure 2f). 
 
To examine Ptp4E protein expression and localization, we generated a variety of 
mouse monoclonal and polyclonal antibodies against Ptp4E. We made a construct that 
consisted of 6x-His-tagged Ptp4E XC domain fused to human placental alkaline 
phosphatase (PTP4E:AP; Figure 1b). PTP4E:AP was expressed in insect cells, 
purified over a Ni-NTA column, and injected into mice. To characterize the resulting 
antibodies, we first stained embryos that overexpressed Ptp4E-GFP using the 
engrailed-GAL4 driver. Figure 2g,h shows double staining of a germ-band extended 
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embryo with anti-Ptp4E (red) and anti-GFP (green). The polyclonal antibodies clearly 
recognize the Ptp4E protein, as anti-Ptp4E (red) signal colocalizes with anti-GFP 
(green) signal in the expected striped pattern. Figure 2i shows a wild-type embryo at 
the same stage stained with anti-Ptp4E, where the expression appears to be 
ubiquitous. Note that the staining between the stripes in Figure 2g is much weaker 
than within the stripes, suggesting that the endogenous protein is expressed at low 
levels. 
 
Although the ubiquitous staining observed with the antibody is consistent with the in 
situ hybridization data, we cannot be sure that antibody staining in wild-type embryos 
is due to Ptp4E protein, because it is not significantly reduced in Ptp4E mutant 
embryos (Ptp4E1 or Df(1)ovo4). This finding could be explained in two ways. First, 
Ptp4E1 mutants might continue to make an abnormal Ptp4E protein(s) due to initiation 
of translation at methionine residues encoded in exons not removed by the excision 
mutation (the second methionine residue in Ptp4E is at amino acid 377, within an 
undeleted exon). This protein, if it exists, would lack a signal sequence and may be 
nonfunctional, because the CNS phenotypes of Ptp4E1 Ptp10D1 and Df(1)ovo4 
Ptp10D1/Y embryos are identical (Figure 3). Df(1)ovo4 deletes the entire Ptp4E gene 
(Figure 1). The presence of antibody staining in Df(1)ovo4 mutants could be due to 
persistence of Ptp4E protein synthesized from maternal mRNA, since early embryos 
contain large amounts of Ptp4E mRNA [25]. Second, it is possible that our Ptp4E 
antibodies cross-react with another ubiquitously expressed protein. They do not cross-
react with Ptp10D, because the signal does not decrease in Ptp10D1 mutant embryos. 
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Although we could not use the antibody to define where Ptp4E is expressed in the 
embryonic CNS in wild-type embryos, its ability to recognize overexpressed Ptp4E 
protein (Figure 2g,h) allowed us to ask whether Ptp4E can localize to axons. To do 
this, we drove Ptp4E-GFP with the pan-neuronal elav-GAL4 driver. In these embryos, 
bright staining of both CNS and peripheral nervous system (PNS) axons is observed 
with anti-Ptp4E and anti-GFP antibodies, and the two patterns are superimposable 
(Figure 2j-o). Interestingly, Ptp4E-GFP also appears to localize to neuronal cell 
bodies in the PNS and CNS (Figures 2j-l). In contrast, Ptp10D, Ptp69D, Lar, and 
Ptp99A, which are restricted to axons in wild-type embryos, are also axon-specific 
when overexpressed (unpublished data). 
 
Expression of Ptp10D protein was detected only in the nervous system in published 
work. It is selectively expressed on embryonic CNS axons [16,17], and in the neuropil 
of the larval and adult brain [28]. Our recent data, however, show that Ptp10D is also 
expressed by embryonic tracheal cells. These findings suggest that the 
embryonic/larval lethality of Ptp4E1 Ptp10D1 animals might be due to either nervous 
system or tracheal phenotypes. In fact, we have found that these embryos have severe 
tracheal defects. These will be described elsewhere (MJ and KZ, manuscript in 
preparation). Their nervous system defects, however, are relatively mild (see below), 
and would not be expected to produce early lethality. Consistent with this, we find 
that GAL4-driven pan-neural expression of a UAS-Ptp4E-GFP fusion, which is 
capable of rescuing the tracheal phenotype when driven in tracheal cells by 
breathless-GAL4 (MJ and KZ, manuscript in preparation), does not rescue lethality in 
the Ptp4E1 Ptp10D1 background. 
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Driving Ptp10D in tracheae with breathless-GAL4 in a Ptp4E1 Ptp10DEP1172 
background (the EP1172 line is a UAS-containing P element insertion upstream of the 
gene, so it allows rescue by crossing in GAL4 drivers) rescues lethality, allowing 
some adults to emerge. These data confirm that lethality in the double mutant is 
rescuable by Ptp10D expression in tracheae (or in other cells that express breathless-
GAL4). We also attempted to rescue lethality by ubiquitous expression of Ptp4E, but 
found that pancellular overexpression of Ptp4E-GFP driven by tubulin-GAL4 is 
lethal. 
 
Analysis of CNS phenotypes in double and triple mutants lacking Ptp4E 
To evaluate CNS defects in multiply mutant embryos, we stained them with a 
monoclonal antibody (mAb), 1D4, and also crossed a SemaIIB-τMyc reporter [29] 
into the mutant backgrounds. mAb 1D4, directed against the cytoplasmic domain of 
Fasciclin II [30], stains three longitudinal bundles on each side of the CNS in stage 17 
embryos. Figure 3 shows 1D4 staining of the CNS in stage 17 wild-type, Ptp4E1, 
Ptp10D 1, Ptp4E1 Ptp10D1, and Df(1)ovo4 Ptp10D1 embryos. In both of the Ptp4E 
double mutant genotypes, a mild fraying of the longitudinal bundles is observed. The 
outer bundle is often incompletely formed, and the outer bundle invades the middle 
longitudinal bundle. The phenotypes of the two genotypes are of approximately equal 
severity, suggesting that Ptp4E1 could be a null mutation. Table 1 shows the 
quantitative comparison of the CNS phenotypes in double and triple mutant 
combinations. 
 
The CNS defects are specific to loss of Ptp4E, because they can be rescued by 
supplying wild-type Ptp4E in neurons. When we drove expression of the UAS-Ptp4E-
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GFP transgene with elav-GAL4, the break and fraying phenotypes were rescued to 
near-wild-type levels. The differences between Ptp4E Ptp10D and the rescued or 
wild-type embryos are both highly statistically significant (p < 0.0001; Table 1). 
There is also a subtle overexpression phenotype produced by driving Ptp4E-GFP in 
neurons, in which the longitudinal bundles have a ‘wavy’ appearance (data not 
shown), 
 
SemaIIB-τMyc is a useful marker for a specific axon pathway that crosses the midline 
in the anterior commissure and then extends anteriorly within the longitudinal tract 
[29]. Staining with anti-Myc antibodies in embryos expressing this reporter in the 
Ptp4E1 Ptp10D1 background reveals that the longitudinal portions of the SemaIIB 
axon pathway exhibit a mild fraying, consistent with the 1D4 results (Figure 3). 
 
Previous work from our group showed that Ptp10D Ptp69D mutants have a specific 
CNS phenotype in which some 1D4-positive longitudinal axons abnormally cross the 
midline. Two distinct longitudinal bundles usually remain in these mutants. The 
Ptp10D Ptp69D combination genetically interacts with robo1, slit, and 
commissureless mutations, and the data suggest that repulsive signalling through 
Robo1 in response to engagement of the midline Slit ligand is reduced in the absence 
of these RPTPs [3]. 
 
Since Ptp4E is similar to Ptp10D, we wondered whether Ptp4E might also genetically 
interact with Ptp69D to produce a synthetic CNS phenotype affecting the 1D4-
positive longitudinal axons. This, however, is not the case. Ptp4E Ptp69D double 
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mutants, like Ptp69D single mutants, have wild-type 1D4 and SemaIIB-τMyc patterns 
(Table 1, Figure 4a,e). 
 
We then asked whether removal of both Ptp4E and Ptp10D together with Ptp69D 
would generate a new synthetic phenotype. We observed that the Ptp4E Ptp10D; 
Ptp69D triple mutant has a strong 1D4 phenotype, with extensive ectopic midline 
crossing (Figure 4f, Table 1). The 1D4 pattern shows midline crossing defects like 
those observed in Ptp10D Ptp69D mutants [3], in which a 1D4-positive bundle 
crosses in the posterior commissure, but the crossing bundle often is thicker than in 
the double mutants (Figure 4f, asterisk). 
 
The longitudinal tracts look different from those in Ptp10D Ptp69D mutants, because 
they have more distinct bundles. In Ptp10D Ptp69D, two 1D4 bundles are observed 
that sometimes fuse into one, and the CNS is narrowed, suggesting that the outer 
bundle is missing (Figure 4b). In the triple mutants, there are always two, and 
sometimes three, longitudinal bundles. Extensive fusion and breakage of the bundles 
are observed, however (Figure 4f). 
 
When examined with SemaIIB-τMyc, the Ptp10D Ptp69D double mutant displays 
occasional ectopic crossing by single axons in the posterior commissure (Figure 4c, 
arrowhead). Rare embryos have much more severe phenotypes in which the axons 
stall along the longitudinal pathways (Figure 4d, asterisk), and axons project out of 
the CNS rather than along the longitudinal tracts (Figure 4d, arrows). The triple 
mutant is observed to have more ectopic midline crossing in the posterior commissure 
than does the double mutant, and the crossing bundles are thicker (Figure 4g, 
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arrowhead; Figure 4h). In one segment of Figure 4h, all of the axons that should 
project anteriorly appear to cross instead (top arrowhead). Other axons start crossing 
and then stall (Figure 4g, asterisk). We never observed SemaIIB axons that projected 
out of the CNS in triple mutant embryos (n = 10). It is difficult to say whether 
removing Ptp4E from a Ptp10D Ptp69D double mutant suppresses or enhances the 
double mutant phenotype. The phenotype changes, so that the outer 1D4 longitudinal 
bundle is restored in some segments of triple mutants. However, more ectopic 
crossing of SemaIIB axons is observed, and the ectopically crossing 1D4 bundles are 
often thicker. 
 
What does this pattern of phenotypic interactions imply about the roles of these three 
RPTPs in CNS axon guidance? First, the existence of the synthetic Ptp10D Ptp69D 
phenotype indicates that Ptp10D and Ptp69D have redundant functions with regard to 
control of midline crossing, and that the activities of Ptp10D that are compensated for 
by Ptp69D with respect to midline crossing are not shared with Ptp4E. Second, there 
could be additional Ptp69D functions in CNS axonal guidance that are redundant with 
Ptp4E activities that are not shared between Ptp4E and Ptp10D. However, elimination 
of these activities in Ptp4E Ptp69D double mutants does not produce a strong 1D4 or 
SemaIIB phenotype. Third, when all functions of the Ptp10D/Ptp4E subfamily of 
RPTPs are eliminated, the 1D4 and SemaIIB phenotypes are still weak because these 
functions are mostly redundant with activities of Ptp69D. Finally, when all the 
Ptp10D/Ptp4E functions are removed together with the Ptp69D functions, the 
phenotype is subtly altered relative to the Ptp10D Ptp69D phenotype. The lack of a 
strong synthetic triple mutant phenotype suggests that Ptp4E is a relatively minor 
player in regulation of CNS axon guidance. 
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An earlier study from our group examined CNS axons in double, triple, and quadruple 
mutant combinations of Lar, Ptp10D, Ptp69D, and Ptp99A mutations [4]. Strikingly, 
in this paper it was found that Lar Ptp69D Ptp99A and Ptp10D Lar Ptp99A triple 
mutants both have an almost normal pattern of 1D4-positive longitudinal axons, but 
when the fourth RPTP is removed as well (in a Ptp10D Lar Ptp69D Ptp99A 
quadruple mutant) all of the 1D4-positive longitudinal pathways are converted to 
commissural pathways that cross the midline. Thus, Lar and Ptp99A can have a strong 
effect on CNS axon guidance, but only when they are removed together with both 
Ptp10D and Ptp69D. 
 
We wondered whether analysis of other mutant combinations involving Ptp4E would 
produce results consistent with the idea that strong synthetic 1D4 CNS phenotypes are 
unique to combinations in which both Ptp10D and Ptp69D are mutant, as suggested 
by [4]. To examine this, we made Ptp4E Lar, Ptp4E Ptp52F, and Ptp4E Ptp99A 
double mutants, and Ptp4E Ptp10D Lar and Ptp4E Ptp10D Ptp52F triple mutants. 
Ptp4E Lar and Ptp4E Ptp99A mutants had no detectable alterations in 1D4-positive 
CNS longitudinal tracts. Ptp4E Ptp10D Lar mutants had phenotypes like those of 
Ptp4E Ptp10D double mutants, indicating that there are no important longitudinal 
axon guidance functions that are redundant between the Ptp10D/Ptp4E protein pair 
and Lar. Ptp52 mutants are the only Rptp single mutants that have a detectable 1D4 
phenotype [5]. Ptp4E Ptp52F mutants had 1D4 phenotypes indistinguishable from 
Ptp52F single mutants, while Ptp4E Ptp10D Ptp52F triple mutants had stronger 
phenotypes. However, we had already demonstrated that Ptp10D Ptp52F double 
mutants have a more disorganized pattern of 1D4-positive bundles than Ptp52F single 
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mutants [5]. The Ptp4E Ptp10D Ptp52F triple mutant does not show an obvious 
enhancement of phenotype relative to the Ptp10D Ptp52F double mutant (data not 
shown). In summary, of the eight mutant combinations involving Ptp4E that we 
examined, only the triple mutant that lacks both Ptp10D and Ptp69D has a strong 
CNS phenotype that is detectable with the markers used in this study. This phenotype 
is much like the Ptp10D Ptp69D double mutant phenotype, but differs from it in some 
subtle ways. 
 
Roles of the Ptp10D/Ptp4E subfamily in motor axon guidance 
We also used mAb 1D4 staining to evaluate the motor axon phenotypes in all of these 
mutant combinations. There are approximately 36 motor neurons in each abdominal 
hemisegment. Motor axons exit the CNS in two main nerve roots (ISN and SN), then 
split into five distinct nerve branches. ISNd and SNc innervate ventral muscles, ISNb 
innervates ventrolateral muscles (VLMs), SNa innervates lateral muscles, and ISN 
innervates dorsal muscles. The patterns of motor axons in segments A2-A7 are 
essentially identical, so it is possible to quantitatively score phenotypes in up to 12 
hemisegments per embryo. 
 
Earlier work from our group and others showed that Rptp mutations affect every 
guidance decision made by these motor axon branches (with the exception of SNc 
branching, which has not been studied). Lar and Ptp52F are the only single mutants 
that have strong phenotypes. Lar mutations produce a ‘parallel bypass’ phenotype 
(approximately 30% penetrance in zygotic nulls), in which the ISNb axons leave the 
common ISN pathway at the exit junction but then fail to enter the VLM field. ISNd 
also fails to extend (approximately 80% penetrance) in these mutants [2,19]. Ptp52F 
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regulates bifurcation of the SNa nerve. One of the two SNa branches (anterior/dorsal 
or posterior/lateral) is missing in approximately 40% of hemisegments in zygotic null 
mutants [5]. 
 
When double, triple, and quadruple combinations of Rptp mutations were analyzed, 
we observed that other decisions are perturbed in specific patterns. Each combination 
of mutations has a unique phenotype, and the data suggest that specific RPTPs are 
required for each pathway choice made by motor axon growth cones. This is 
described for ISNb guidance in the Background section. Another example is extension 
of the ISN past branchpoints in the dorsal muscle field. In Lar single mutants, the ISN 
usually reaches its normal termination point but arborization on muscle 1 is reduced. 
In the absence of both Lar and Ptp69D, the ISN stops at the second branchpoint near 
muscle 2, while in Lar Ptp69D Ptp99A triple mutants it stops at the first branchpoint 
near muscle 3 [19]. 
 
Not all combinations of Rptp mutations produce phenotypic enhancement. Ptp99A 
and Lar have opposing activities in controlling ISNb entry into the VLM field. Thus, 
in the strongest Lar mutant combination only 40% of ISNb branches successfully 
enter the VLM field, while in Lar Ptp99A double mutants this phenotype is almost 
completely suppressed, and approximately 96% of ISNbs enter the muscle field in a 
normal manner [4,19]. 
 
For the first four RPTPs to be analyzed (Lar, Ptp69D, Ptp99A, Ptp10D), it was 
possible to construct and analyze all 15 possible single, double, triple, and quadruple 
mutant combinations, and thus obtain a complete picture of the genetic relationships 
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among these signalling molecules [4]. When we identified mutations in the fifth gene, 
Ptp52F, it became impossible to make and analyze every combination, so we 
examined only double mutants [5]. These two studies led to the conclusion that 
Ptp10D is relatively unimportant, relative to the other RPTPs, for regulation of motor 
axon guidance. This conclusion is opposite to that reached for CNS axon guidance, 
where we observe ectopic midline crossing only in genotypes where Ptp10D is 
missing [4]. 
 
Enhancement of Ptp52F phenotypes is observed in Ptp10D Ptp52F double mutants, 
so that ISNb ‘stall’ phenotypes, in which the ISNb stops short of its normal 
termination point at the ventral edge of muscle 12, and ISN truncation phenotypes are 
observed more frequently [5]. These are the only double mutants involving Ptp10D 
that exhibit phenotypic enhancement relative to the corresponding single mutant. 
Ptp10D mutations increase the penetrance of some double and triple mutant motor 
axon phenotypes involving Lar, Ptp69D, and Ptp99A, and decrease the penetrance of 
others [4]. 
 
We wondered whether this apparent lack of a role for Ptp10D in motor axon guidance 
arises from the fact that Ptp10D is the only RPTP in Drosophila that has a paralog 
within the same subfamily. Each of the other RPTPs appears to represent its own 
subfamily. The Lar subfamily has a representative in C. elegans and three members in 
mammals, while Ptp69D and Ptp99A each have one worm counterpart but no obvious 
mammalian orthologs [5]. Ptp52F has similarities to type III RPTPs, but has a unique 
amino-terminal sequence and appears to be unique to drosophilids (unpublished 
results). Because of their close sequence relationship, the loss of Ptp10D function in 
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the motor axon system might be compensated for by the presence of Ptp4E. This 
model predicts that Ptp4E double mutant combinations also would not exhibit 
phenotypic enhancement relative to the corresponding single mutants. Indeed, we 
found this to be the case: no motor axon phenotypes are observed in Ptp4E Ptp99A 
mutants, and the phenotypes seen in Ptp4E Ptp69D, Ptp4E Lar, and Ptp4E Ptp52F 
mutants are no stronger than in the corresponding Ptp69D, Lar, and Ptp52F single 
mutants. We also found that removal of both members of the Ptp10D subfamily, in 
Ptp4E Ptp10D double mutants, does not produce motor axon phenotypes, suggesting 
that the subfamily has no essential role in motor axon guidance that is not 
compensated for by the presence of one of the other RPTPs (Table 2 and data not 
shown). 
 
We then asked whether strong phenotypic interactions might be observed in triple 
mutants lacking both Ptp4E and Ptp10D together with one of the other subfamilies. If 
so, this would indicate that there are motor axon guidance functions that are redundant 
between the Ptp10D subfamily and another subfamily, so that synthetic phenotypes 
would be observed only when both subfamilies are eliminated. To examine this 
question, we analyzed the triple mutants described above for motor axon phenotypes. 
Our data show that Ptp4E Ptp10D Lar mutants do not have any new phenotypes, and 
also do not exhibit phenotypic enhancement relative to Lar single mutants (Table 2). 
Thus, as for CNS axon guidance, there appear to be no important functions of the 
Ptp10D/Ptp4E subfamily that are uncovered by removal of Lar. 
 
For the other two triple mutant combinations, however, we did observe phenotypic 
enhancement by removal of both Ptp4E and Ptp10D. Ptp4E Ptp10D Ptp69D triple 
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mutants have a stronger ISNb phenotype than any of the component double mutants. 
This is a ‘clump’ phenotype in which 90% of ISNbs terminate in a darkly staining 
blob at the dorsal border of muscle 6 (Figures 5l,m). In cases where the ISNb passes 
this point, it is often misrouted (Figure 5k, right hemisegment), or bypasses the 
muscle field (Figure 5l) by growing along the ISN. As in bypass phenotypes seen in 
other mutants, the axons often ectopically project interiorly to muscle 12 from the ISN 
(Figure 5l, right arrow), suggesting that they retain an affinity for this muscle. Ptp10D 
Ptp69D double mutants have a similar percentage of ISNb branches that fail to reach 
muscle 12 (stall phenotype); however, these branches maintain a growth cone-like 
appearance (Figure 5j). 
 
In almost every affected triple mutant hemisegment, the ISNb clump is at the same 
point. These data suggest that extension of ISNb axons onto muscle 13 might require 
a specific signalling event(s) that can be mediated by either a type III RPTP or by 
Ptp69D. In contrast, for most other published Rptp stall phenotypes (for example, 
Ptp69D Ptp99A [1,19]) defective ISNbs terminate at a variety of sites, suggesting that 
loss of the RPTPs produces multiple defects in pathway choice and extension that 
occur in a probabilistic manner. The differences between the triple and double mutant 
phenotypes are highly statistically significant (p < 0.0001; Table 2). 
 
We also observed a subtle phenotypic enhancement for SNa defects. We previously 
showed that Ptp10D Ptp69D double mutants have a SNa defect in which one of the 
branches is missing (13% penetrance of a completely absent branch). For a smaller 
percentage of SNas (10%), both branches are missing or the SNa fails to even reach 
the bifurcation point. In Ptp4E Ptp10D Ptp69D triple mutants, the penetrances of the 
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missing branch phenotypes are similar to those in the double mutant, but an additional 
9% of SNa nerves are very thin (Figure 5f, arrow) or completely absent; this 
phenotype is not seen in Ptp10D Ptp69D (p < 0.0001; Table 2) Also, there are SNa 
nerves that project along abnormal pathways (Figure 5d). 
 
The other major effect on motor axon guidance we observed in response to loss of 
Ptp4E was enhancement of a Ptp10D Ptp52F phenotype in which the ISN is truncated 
at the second branchpoint. This phenotype is observed in about 20% of hemisegments 
in the double mutant. However, the penetrance of second branchpoint truncation 
increases to 60% in the Ptp4E Ptp10D Ptp52F triple mutant (p < 0.0001; Figure 5b, 
Table 2). For the other phenotypes of Ptp10D Ptp52F (SNa bifurcation failure and 
ISNb stalling), we saw only small increases in phenotypic penetrance when Ptp4E is 
removed. 
 
Conclusions 
In Drosophila, five of the six RPTPs were reported to be neural-specific in late 
embryos, and all the zygotic Rptp phenotypes that have been published are axon 
guidance alterations. In contrast, many of the 17 mammalian RPTPs are expressed in 
non-neural cell types and have a variety of functions unrelated to axon guidance. 
Since Ptp4E is the only widely expressed Rptp gene, we speculated that studying its 
mutant phenotype might reveal new functions for Drosophila RPTPs outside the 
nervous system, and that these might provide information about functions of 
mammalian non-neural RPTPs. One might have expected that Ptp4E mutations would 
cause lethality and produce strong phenotypes, since no other RPTPs would be able to 
compensate for the loss of Ptp4E in non-neural cells. This, however, is not the case. 
 - 25 - 
Ptp4E mutants are viable, fertile, and apparently healthy, and have no detectable 
phenotypes in the nervous system or elsewhere. Furthermore, our evolutionary 
analysis indicates that Ptp4E is a relatively recent invention; it is present in 
drosophilids but not in mosquitoes or non-dipteran arthropods. Within the 
drosophilids, its sequence also changes more rapidly than that of Ptp10D, suggesting 
that it has been less constrained by evolution (Figure 1). All of these considerations 
indicate that Ptp4E is not essential for development of non-neural cell types in 
Drosophila. 
 
Perhaps in Drosophila the functions executed by mammalian RPTPs in non-neural 
cell types are carried out by one or more of the eight nonreceptor PTPs. Some of these 
are ubiquitously expressed. Only three have been genetically characterized. Csw and 
PTP-ER are involved in cell fate determination [31,32]. Mutations in ptpmeg produce 
axonal defects in the adult brain [33]. Ptpmeg, however, does not act in the neurons 
that exhibit the axonal phenotypes, but is required in surrounding cells [33]. Thus, it is 
unlikely to participate in growth cone signal transduction in the same manner as the 
RPTPs. 
 
Ptp10D and Ptp4E are the only Drosophila RPTPs that are members of the same 
subfamily; the other four are each the sole fly representative of their subfamily. 
Mutations in three of the other four Rptp genes (Lar, Ptp52F, Ptp69D) cause lethality. 
This suggests that the viability of Ptp10D and Ptp4E single mutants might be due to 
compensation by the other member of the subfamily, and that a Ptp4E Ptp10D double 
mutation would cause lethality. This is in fact observed; the double mutant dies at 
hatching. However, it does not have generalized defects. Rather, the defects we have 
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found are all within the nervous system and the tracheal network. Our unpublished 
data show that Ptp10D is also selectively expressed in tracheal cells (MJ and KZ, 
manuscript in preparation). We suggest that Ptp4E Ptp10D double mutant phenotypes 
are observed only where Ptp10D is expressed. 
 
The analysis described in this paper, together with that in several other papers from 
our group [4,5,19] allow us to assemble complete genetic interaction matrices for 
pairwise combinations of mutations in all six of the Rptp genes. Figure 6a is a matrix 
depicting the functions of the RPTPs in regulation of longitudinal axon guidance in 
the CNS, as assayed by 1D4 staining. The lines represent different types of genetic 
interactions. Red double-headed arrows indicate synthetic phenotypes, where neither 
of the single mutants exhibits a detectable phenotype but the double mutant has a 
phenotype; the arrow thickness indicates the strength of the phenotype. These are seen 
for Ptp10D Ptp69D [3] and Ptp4E Ptp10D (Figure 3). Black arrows indicate 
enhancement of a single mutant phenotype by removal of a second RPTP. In the CNS, 
these are observed only for Ptp52F, since this is the only single mutant that has a CNS 
phenotype detectable with 1D4. Finally, blue lines with bars at the end indicate 
suppression, where removal of a second RPTP suppresses the single mutant 
phenotype. This is observed for Lar Ptp52F mutants [5], and may indicate that these 
two RPTPs function in a competitive manner (in a formal genetic sense) to regulate a 
CNS signalling pathway. 
 
Figure 6b shows the interaction matrix for motor axon guidance. This is different 
from the CNS interaction matrix, so we can conclude that the relationships between 
the RPTP signalling pathways differ in some cases between motor neurons and CNS 
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interneurons. However, Ptp10D Ptp69D double mutants have a synthetic SNa 
phenotype [4], so these two RPTPs interact strongly in regulating both CNS and 
motor axon guidance. Loss of Ptp10D also enhances both the CNS and motor axon 
defects of Ptp52F mutants [5]. 
 
As in the CNS, there are competitive relationships between RPTPs, but they are seen 
for a different RPTP pair. In motor axons, removal of Ptp99A completely suppresses 
the Lar ISNb parallel bypass phenotype [19]. Lar mutations enhance the Ptp52F 
motor axon phenotypes rather than suppressing them as they do in the CNS [5]. 
 
In this paper, we have defined the phenotypes associated with simultaneous 
elimination of the functions of two RPTP subfamilies, by examining triple mutants 
removing both Ptp4E and Ptp10D together with each of the other three RPTPs whose 
absence produces lethality. This analysis shows that the Ptp10D/Ptp4E subfamily is 
redundant with Ptp69D in controlling guidance decisions made by three neuronal 
types, but Ptp4E mutants have relatively minor effects relative to Ptp10D mutants. 
For guidance of 1D4 and SemaIIB axons within the CNS, removal of both members 
of the Ptp10D/Ptp4E subfamily together with Ptp69D modulates the phenotype 
observed in Ptp10D Ptp69D mutants (Figure 4). For SNa axons, the triple mutant has 
an enhanced phenotype, in that 10% of SNa nerves now fail to extend altogether; this 
is almost never observed in double mutants (Figures 5 and 6c). We also observe 
enhancement of a Ptp10D Ptp52F ISN truncation phenotype by removal of Ptp4E 
(Figures 5 and 6c), but no strong interactions between Ptp4E Ptp10D and Lar are 
observed in the CNS or neuromuscular system. 
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These results suggest that there is a special relationship between the Ptp10D/Ptp4E 
subfamily and Ptp69D. Perhaps these two types of RPTPs have similar substrates in 
both CNS interneurons and motor neurons. In CNS neurons, some critical substrate(s) 
dephosphorylated by Ptp69D might also be dephosphorylated by either Ptp10D or 
Ptp4E, so that certain phenotypes, such as crossing of all the SemaIIB axons in the 
wrong commissure (Figure 4h), are observed only when all three RPTPs are 
eliminated. However, in CNS neurons such as the neuroblast 2-5 lineage, whose 
axons ectopically cross the midline in Ptp10D Ptp69D double mutants [3], Ptp4E 
cannot compensate for the loss of Ptp10D. Perhaps in these cells the relevant Ptp69D 
substrate(s) can be dephosphorylated by Ptp10D but not by Ptp4E; however, this 
seems unlikely given that Ptp4E and Ptp10D have PTP domains that are much more 
similar to each other than are those of Ptp69D and Ptp10D. Alternatively, perhaps the 
Ptp4E concentration is too low in these neurons for efficient dephosphorylation to 
occur. Another possibility is that growth cones of these neurons contact Ptp10D 
ligands, but not Ptp4E ligands, and that ligand contact is required for signalling. An 
understanding of the biochemical origins of these genetic interactions will require 
identification and characterization of RPTP ligands, substrates and downstream 
signalling proteins, as well as localization of these proteins to specific neuronal types. 
 
Materials and methods 
Drosophila stocks and transgenic flies 
Ptp4E1 was generated by imprecise excision of EP425 [34] inserted 1,157 nucleotides 
upstream of the transcription start. PCR was used to map the deletion endpoints. The 
deletion removes approximately 10.5 kb, starting from 130 bp upstream of the EP425 
insertion site to before the start of exon 3. The excision event introduced 
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chromosomal rearrangement, and as a result there are unrecognizable sequences 
between the endpoints. 
 
The following Rptp mutant flies were used: Ptp10D1 [3]; Ptp69D1 and Df(3L)8ex25 
[1]; Lar5.5 and Lar 13.2 [2]; Ptp52F18.3 [5]. Lethal mutations were balanced over GFP 
balancer chromosomes for sorting homozygous mutant embryos. Double and triple 
mutant lines were checked for the presence of Ptp4E1 by PCR. Elav-GAL4 was 
obtained from Bloomington Stock Center (Bloomington, IN, USA). All crosses were 
carried out at 25°C. 
 
The UAS-Ptp4E-GFP construct was made by PCR amplification of the entire coding 
region of the long Ptp4E cDNA, Ptp4E-A, and cloning it into the Gateway System 
vector (DGRC, Bloomington, IN, USA). The vector used placed a GFP sequence 
downstream of the Ptp4E coding sequence. The entire construct was sequenced, and 
also expressed in S2 cells to check for GFP expression to verify that PCR errors were 
not introduced into the clone. Ptp4E-GFP DNA was injected into embryos using 
standard methods to generate transgenic flies. Multiple lines were generated and 
examined; UAS-4E-GFP#4/CyO was used for all studies. 
 
Generation of Ptp4E antibodies 
To generate antibodies against the native protein, we made a construct 4E-AP that 
was expressed in insect cells using a baculovirus expression system. The 4E-AP 
construct was made by dropping in a 2.7 Psi I/Kpn I fragment from Ptp4E-A 
(extracellular domain amino acids 169-1073) into a modified baculovirus expression 
vector pAcGP67-A (BD Biosciences, San Jose, CA, USA). The vector contains a 
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pg67 secretion signal sequence followed by a 6x-His tag, placed upstream of the 
Ptp4E insertion site. The sequence for human placental alkaline phosphatase was 
placed in frame, carboxy-terminal to the Ptp4E sequence. The protein expressed 
consists of the gp67 signal peptide-6xHis-Ptp4E-AP fusion protein that was harvested 
from insect cell media. Protein was concentrated ten-fold, then purified over a Ni-
NTA column (Qiagen, Valencia, CA, USA) . Conditions used are: binding buffer (10 
mM imidazole, 300 mM NaCl, 20 mM, Tris pH8.0), wash buffer (25 mM imidazole, 
300 mM NaCl, 20 mM, Tris pH8.0), and elution buffer (250 mM imidazole, 300 mM 
NaCl, 20 mM, Tris pH8.0). Purified protein was injected at approximately 100 µg per 
boost. Antibodies were generated at the Caltech Monoclonal Facility. 
 
Whole-mount in situ hybridization and immunohistochemistry 
Embryos were collected overnight, fixed and hybridized with digoxigenin-UTP 
antisense RNA probe. Probes were generated from approximately 750 bp PCR 
product amplified from Ptp4E cDNA that corresponds to the first four exons. 
Conditions were used as previously described in [35] with some modifications. 
 
Whole-mount antibody staining of stage 16-17 embryos was performed using 
standard procedures [36], with some variations. Embryos were fixed for 20 minutes 
with 4% paraformaldehyde. Washes were done in 0.1% PT (0.1% Triton X-100 in 
phosphate-buffered saline), and blocking buffer used was PT with 0.1% bovine serum 
albumin + 5% normal goat serum. Double and triple mutant embryos were balanced 
over GFP balancer chromosomes and homozygous mutants were sorted for lack of 
GFP expression. Anti-GFP and mAb 1D4 were simultaneously incubated on embryos. 
Alexa-488 conjugated secondary antibodies were used against anti-GFP, and non-
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green embryos were sorted under an epifluorescent dissecting microscope. These 
embryos were then treated with horseradish peroxidase (HRP) immunohistochemistry 
using standard procedures [36] to visualize 1D4 staining pattern. 
 
In cases where RPTP specific antibodies were used for sorting, staining was done in a 
sequential manner. Embryos were first incubated with RPTP antibodies, sorted, and 
then incubated with 1D4. For some of the triple mutant combinations, live embryos 
were sorted under the epifluorescent dissecting microscope, then dissected live on 
Superfrost/Plus adhesion slides (Fisher Scientific, Pittsburgh, PA, USA) in phosphate-
buffered saline. These live dissected embryos were fixed on the slide, and carried 
through the same procedures as whole-mount embryo staining procedure. 
 
Primary antibodies were used at the following dilutions: anti-GFP (Invitrogen, 
Carlsbad, CA, USA) at 1:1,000, mAb 1D4 at 1:3, mouse anti-Ptp4E (polyclonal) at 
1:500, mouse anti-Ptp10D (8B2) at 1:3; mouse anti-Ptp69D (2C2) at 1:3, mouse anti-
Myc (clone 9E10, Sigma, St. Louis, MO, USA) at 1:250. Secondary antibodies used 
were: Alexa Fluor 488 and Alexa Fluor 568 (Invitrogen) at 1:1,000, HRP-conjugated 
goat anti-mouse IgG+IgM (Jackson ImmunoResearch Laboratories, Inc., West Grove, 
PA, USA). Samples were mounted on Vectashield (Vector Laboratories, Burlingame, 
CA, USA) or glycerol. Samples were photographed on the Zeiss Axioplan microscope 
using DIC optics. Fluorescent images were taken on Zeiss LSM510, and images were 
processed using Adobe Photoshop. 
 
Phylogenetic tree 
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Phylogenetic tree construction was performed using the software Geneious Pro, 
available at [37]. The accession numbers of sequences are the following. Ptp4E-PA: 
AAF45998 (melanogaster), CH940655 (virilis), CH902621 (ananassae). Ptp10D-PA: 
AAS65319 (melanogaster), CH940655 (virilis), CH902630 (ananassae). Aedes 
aegypti, AAEL012083. Anopheles gambiae, AGAP004246. Apis mellifera, GB19351.  
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{Figure legends} 
 
Figure 1 
Organization of the Ptp4E gene and protein, and evolutionary analysis. (a) The EP425 
element that was used to generate the ptp4E1 allele was inserted 1,157 nucleotides 
upstream of the transcription start site. The portions of the gene deleted in ptp4E1 and 
Df(1)ovo4 are shown with a solid line when confirmed by PCR, and with a dotted line 
to show that the endpoint lies within the dotted region. Df(1)ovo4 is the smallest 
deficiency that removes Ptp4E. (b) Domain organization of Ptp4E protein, and the 
segment that was included in the 4E-AP construct. Ptp4E consists of a hydrophobic 
region (HD) and 11 fibronectin type III repeats (FN-III) in the extracellular (XC) 
domain, and a single putative catalytic phosphatase domain in the intracellular region. 
The 4E-AP construct that was used to express protein consists of a secretion signal 
peptide sequence (pink), 6x His residues (blue) followed by Ptp4E XC domain and 
human placental alkaline phosphatase sequence. (c) Comparison of Ptp4E ad Ptp10D 
protein structure arrangement and sequence comparison. Ptp4E and Ptp10D are very 
similar in structure and are 54% identical along the entire length of the protein. (d) 
Phylogenetic tree indicating that non-drosophilid species have only one copy of 
Ptp4E/Ptp10D, which is more similar to Ptp10D than to Ptp4E. Ptp10D is likely to be 
the ancestral copy. This is visualized in the tree by comparing the branch lengths 
connecting Ptp4E and Ptp10D to other insect species. D. melanogaster Ptp10D is 
closer than Ptp4E to the sequences in other insects that have only one type III RPTP 
gene, indicating greater sequence similarity. Also, the Ptp4E sequence evolved much 
faster than the Ptp10D sequence after the duplication (compare the branch lengths 
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within the melanogaster/ananassae/virilis cluster for the two genes). A. gambiae, 
mosquito; A. aegypti, mosquito; A. mellifera, honey bee. 
 
Figure 2 
Ptp4E expression and protein localization during embryogenesis. (a-f) Expression of 
Ptp4E during development was visualized by in situ hybridization of whole-mount 
embryos. In all panels, anterior is left and dorsal is up, except for (c), which shows a 
ventral view. (a) At stage 8, in gastrulating embryos, Ptp4E expression is enriched in 
the mesoderm (labelled m). (b,c) In germ band extended stage 11 embryos, Ptp4E is 
expressed at highest levels in the posterior midgut primordium (PMG) and also shows 
a scalloped pattern that corresponds to the visceral mesoderm (vm). (d) As a positive 
control, we also stained embryos where UAS-Ptp4E-GFP was driven using the 
engrailed-GAL4 driver. The characteristic striped engrailed pattern is observed, 
indicating that the probe recognizes Ptp4E transcripts. (e) At stage 15, the strongest 
Ptp4E signal is in the midgut (mg); the ventral nerve cord (CNS) is also visible 
(arrow). (f) At stage 17, the gut is segmented and starts to coil. Ptp4E is expressed at 
highest levels at the anterior and posterior ends of the midgut and in the hindgut (hg). 
(g-o) Anti-Ptp4E antibodies recognize ectopically expressed Ptp4E-GFP. (g,h) The 
UAS-Ptp4E-GFP construct was ectopically expressed using the engrailed-GAL4 
driver in stage 11 embryos. Anti-Ptp4E signal (g; red) colocalizes with theUAS-
Ptp4E-GFP (visualized with anti-GFP; h, green) expression pattern, indicating that the 
antibody specifically recognizes the Ptp4E protein. (i) In wild-type embryos, the 
antibody shows a low and ubiquitous signal. Ptp4E-GFP protein was expressed in all 
postmitotic neurons using elav-GAL4 (j-o). Stage 16 embryo was visualized with 
anti-Ptp4E (j,m), anti-GFP (k,n), and merged (l,o). Ptp4E-GFP protein is transported 
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out to the axons (m-o) as the CNS ladder brightly stains with anti-Ptp4E and anti-
GFP. Ptp4E also accumulates in cell bodies, since the CNS region outside of the axon 
tracts stains brightly (j,k,m,n, arrows). PNS cell bodies (chordotonal organs) are also 
visible (j,k, arrowheads). (j-l) Images are projections of confocal stacks. (m-o) Images 
are single confocal sections. Scale bars are 35 microns (a-i) and 20 microns (j-o). 
 
Figure 3 
CNS phenotype of Ptp4E Ptp10D double mutants. (a-d,h) Stage 17 embryos were 
stained with mAb 1D4 and visualized using HRP immunohistochemistry. (e-g) Stage 
17 embryos expressing the transgene SemaIIb-τmyc were stained with anti-Myc 
antibodies, and images are projections of confocal stacks. (a) Wild-type embryos at 
stage 17 show three distinct longitudinal tracts on either side of the midline. 
Commissural bundles do not stain with 1D4 at this stage, although cell bodies 
showing light staining are visible here. Ptp4E1 (b) and Ptp10D1 (c) embryos do not 
show any defects in CNS axon guidance, and are indistinguishable from control w1118 
CNS (a). The double mutants Ptp4E1 Ptp10D1 (d) and Df(1)ovo4 ptp10D1 (h) show 
mild CNS defects. The longitudinal axons appear wavy and the outermost 
longitudinal axon tract is discontinuous and often invades the middle (intermediate) 
longitudinal axon tract (arrowheads). SemaIIB axons were visualized using the 
SemaIIb-τmyc transgene. (e) In the wild-type CNS, semaIIb-τmyc expressing axons 
project across the midline along the anterior commissural bundle and extend 
anteriorly along the intermediate 1D4 fascicle (arrows indicate the direction of axon 
trajectory). (f,g) SemaIIb-τmyc axons project in a normal manner in the double 
mutants. However, they have a consistent defect within their longitudinally projecting 
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segment, in which the axon bundles do not form a tight bundle but have a frayed 
appearance (arrowheads). Anterior is up in all panels. Scale bars are 10 microns. 
 
Figure 4 
CNS axon guidance defects in double and triple mutants. Stage 17 embryos were 
stained with (a,b,f) 1D4 and (c-e,g,h) anti-Myc as in Figure 3. (a) The Ptp4E, Ptp69D 
CNS shows very mild defects with 1D4 in which the outer longitudinal bundle is 
slightly wavy. (e) The SemaIIb-τmyc axons are almost indistinguishable from wild-
type, although there is some slight fraying of the longitudinal segments of the 
pathways. (b) The Ptp10D; Ptp69D CNS has a strong ectopic midline crossing defect 
in which 1D4 axons grow across the posterior commissure (arrow); a thinner bundle is 
observed in the anterior commissure (arrowhead). Only one or two longitudinal 
bundles are visible, and the width of the CNS axon ladder indicates that the outer 
bundle is missing. (c) SemaIIb-τmyc axons in Ptp10D; Ptp69D. A thin axon bundle 
crosses the CNS in the posterior commissure (arrowhead). (d) An extreme Ptp10D, 
Ptp69D phenotype, with axons that project out of the CNS (arrows), and stalled 
growth cones along the longitudinal tract (asterisk). (f) 1D4 staining in Ptp4E 
Ptp10D; Ptp69D triple mutants show thick bundles that cross the midline in each 
segment (asterisk). There are two or three distinct longitudinal bundles (arrowhead). 
(g,h) Thick bundles of SemaIIb-τmyc axons in the triple mutant cross the midline in 
the posterior commissure (g, arrowhead; h, top arrowhead). A stalled axonal 
projection in this commissure is seen in (g, asterisk). Other abnormally crossing axons 
are indicated with arrowheads in (h). Anterior is up in all panels. Scale bars are 10 
microns. 
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Figure 5 
Motor axon defects in triple mutants. Stage 16 or 17 embryos were stained with 1D4 
and visualized using HRP immunohistochemistry. (a) In wild-type stage 16 embryos, 
ISN reaches its target and synapses with muscles 1 and 9 (asterisk) at a position distal 
to the tracheal dorsal trunk (shown in dotted lines). (b) In a Ptp4E Ptp10D; Ptp52F 
triple mutant embryo, ISN stalls at the second branch point (asterisk). (c) Wild-type 
SNa bifurcates (bifurcation point shown in arrowhead) and extends an anterior branch 
(left) and a posterior branch (right). (d-f) In Ptp4E Ptp10D; Ptp69D triple mutants, 
SNa shows various defects. Some branches are very thin (d, arrowhead) or almost 
undetectable (f, arrow). The branch on the right in (f, arrowhead) is normal. The left 
SNa in (e) has only stubs at the branchpoint (arrowhead). The SNa on the right 
abnormally projects beyond the muscle 22/23 bifurcation cleft and sends a thin 
projection toward an abnormal ISN side branch (e, asterisk). (g,h) The SNa in 
Ptp10D; Ptp69D embryos. Extra branch is shown on the anterior branch (g, asterisk), 
and a very short anterior branch is observed in (h, asterisk). (i) Wild type ISNb. At 
stage 17, synapses have begun to form at the muscle 12/13 cleft and at the bottom of 
muscle 13. (j) Ptp10D; Ptp69D stage 17 embryo shows ISNb branches with growth-
cone-like morphologies that end at muscle 13. (k-m) ISNb defects in Ptp4E Ptp10D; 
Ptp69D triple mutants. (k) The ISNb on the right has an abnormal trajectory and stalls 
at muscle 13. (l,m) The same hemisegments, imaged in different focal planes. The 
characteristic clumped phenotype is seen in the left hemisegment (l, left arrow). The 
right hemisegment has a stall/bypass phenotype in which some ISNb axons grow out 
along the ISN, producing an ectopic branch onto muscle 12 (l, right arrow). In the 
middle hemisegment, thin branches also emerge from the clump and grow onto the 
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surface of muscle 13 (m, arrowhead). Anterior is left and ventral is down in all panels. 
All scale bars are 10 microns.  
 
Figure 6 
Summary of pairwise genetic interaction among all six RPTPs. Matrices depict role of 
RPTPs in CNS longitudinal axon guidance (a) and motor axon guidance (b).  (c) 
Interaction of Ptp4E Ptp10D double mutant with RPTPs.  Ptp4E shows enhancement 
of motor axon guidance phenotypes observed in Ptp10D Ptp69D and Ptp10D Ptp52F 
double mutants. Thicker lines indicate stronger genetic interaction than thinner lines. 
Red double headed arrows indicate synthetic genetic interactions. Black single headed 
arrows indicate enhancement/cooperation, and the blue lines indicate genetic 
suppression.  
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Table 1 
CNS axon phenotypes in Rptp double and triple mutant embryos 
 Phenotype (%) 
Genotype n Two One/none Cross-over 
Ptp4E1  128 2 0 0 
Ptp10D1 128 1 0 0 
Ptp4E1 Ptp10D1; UAS-4E-GFP/elav 124 7* 0 0 
Ptp4E1 Ptp10D1 126 30† 0 1 
Ptp4E1; Ptp69D1/Df(3L)8ex25 80 3 0 0 
Ptp10D1; Ptp69D1/Df(3L)8ex25 128 63 21 100 
Ptp4E1 Ptp10D1; Ptp69D1/Df(3L)8ex25 106 54 16 100 
CNS longitudinal axons were scored by counting the number of longitudinal tracts in 
each hemisegment at the midpoint between commissures (visualized by residual 1D4 
staining at stage 17). In wild-type embryos, there are three fascicles per hemisegment.  
n, total number of hemisegments (T2-A6) scored at stage 17. Two: hemisegments 
with only two longitudinal tracts where the outer bundle is missing or is fused to the 
medial fascicle. One/none: hemisegments with only one or no longitudinal tracts. 
Cross-over: segments where axons abnormally cross the midline. *Expression of 
UAS-4E-GFP in neurons using the elav-GAL4 driver produces incomplete rescue 
(from 30% to 7%, versus 1-2% in single mutants). However, the statistical difference 
between Ptp4E1 Ptp10D1and Ptp4E1 Ptp10D1; UAS-4E-GFP/elav was highly 
significant (p < 0.0001, Chi-square test), indicating that pan-neural expression of 
Ptp4E rescues.  †Statistical differences between Ptp4E1 Ptp10D1and each of the single 
mutants were also significant (p < 0.0001, Chi-square test). 
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Table 2 
Motor axon phenotypes in Rptp double and triple mutant embryos 
 
Phenotype (%)* 
Genotype  
ISN n t T SB FB  
Ptp4E1 Ptp10D1 155 6 3 3 0  
Ptp4E1; Ptp52F18.3 126 12 2 8 2  
Ptp10D1; Ptp52F18.3 207† 67 40 23 4  
Ptp4E1 Ptp10D1; Ptp52F18.3 203 74 11 60‡ 3  
Dlar5.5/Dlar13.2 256§ 41 22 19 0  
Ptp4E1; Dlar5.5/Dlar13.2 91 51 30 21 0  
Ptp4E1 Ptp10D1; Dlar5.5/Dlar13.2 133 60 32 26 2  
 
      
ISNb n t B S C  
Ptp4E1 Ptp10D1 119 2 0 2 0  
Ptp4E1; Ptp69D1/Df(3L)8ex25 106 11 8 3 0  
Ptp10D1; Ptp69D1/Df(3L)8ex25 101 94 4 90¶ 0  
Ptp4E1 Ptp10D1; Ptp69D1/Df(3L)8ex25 108 93 1 36¶ 56¶  
 
      
SNa n t M S A - 
Ptp4E1 Ptp10D1 139 5 3 1 1 0 
Ptp4E1; Ptp69D1/Df(3L)8ex25 122 7 5 1 1 0 
Ptp10D1; Ptp69D1/Df(3L)8ex25  85 26 13 10 2 1 
Ptp4E1 Ptp10D1; Ptp69D1/Df(3L)8ex25 106 41 18 14 0 9¥ 
n, number of hemisegments (A2-A7) scored; t, all affected branches. For ISN 
phenotype categories: T, ISN branches that end at the normal terminal arbor 
position but are thin or bifurcated; SB, ISNs that terminate at the second 
branchpoint; FB, ISNs that terminate at the first branchpoint. For ISNb phenotype 
categories: B, ISNb branches that bypass the ventrolateral muscle field (muscles 6, 
7, 12, 13) and grow adjacent to ISN or fail to exit the ISN pathway and are fused to 
ISN; S, ISNbs that stall within the VLM field or fail to enter the VLM field; C, 
ISNbs that stall with a clump. For SNa phenotype categories: M, either posterior or 
anterior branch is missing; S, SNa branches stall near the bifurcation point; A, 
additional branches; -, the whole branch is very thin or absent. *The numbers listed 
are percent of hemisegments that display a phenotype. †The results for Ptp10D1; 
Ptp52F18.3 were published in [5]. ‡For ISN motor axons, the differences between 
the triple mutant and each of the double mutants (Ptp4E Ptp52F and Ptp10D 
Ptp52F) are statistically significant (p < 0.0001, Chi-square test). §The results for 
Dlar5.5/Dlar13.2 were published in [19]. ¶While approximately 90% of ISNbs end at 
the base of m13 in both genotypes, the phenotype is different in the triple mutant: 
56% of stalled ISNb axons in triple mutants form a clump, whereas in the double 
mutant they simply resemble earlier (stage 16) axons with growth-cone like 
morphologies. These embryos were scored with genotypes blinded by another 
observer to make sure we could distinguish the phenotypes. The difference between 
the triple and the double mutants is highly statistically significant (p < 0.0001, Chi-
square test). ¥Difference between the triple and the double mutant (Ptp10D Ptp69D) 
is statistically significant (p < 0.0001, Chi-square test). 
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